Trump Administration Proposes MFN Deals in Pharmacy Sector
Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.
Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.
Explore the new Ambulatory Specialty Model by CMS, focusing on value-based reimbursement for cardiologists in heart failure care. Learn its implications and requirements.
Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.
Explore the intricacies of Medicare, vital for retirement planning. Understand enrollment periods, benefits, and essential coverage options for optimal decision-making.
Discover how telehealth for Medicare beneficiaries has evolved, with 60 million appointments in 2023, ensuring healthcare access for older adults.
Explore how rising prescription drug costs affect Medicare beneficiaries and learn about the Extra Help program for affordable medications.
Explore urgent reforms needed in Medicare's GME payments to address physician shortages and improve healthcare access in rural areas. A call to action for Congress.
Discover how the Promoting Fairness for Medicare Providers Act impacts reimbursement rates and insurance offerings for seniors, ensuring better healthcare access.
CMS initiates a temporary coverage program for GLP-1 medications aiming to assist Medicare beneficiaries before full BALANCE Model implementation. Learn more.
Explore the ongoing impact of the Affordable Care Act on health insurance, regulatory compliance, and patient care initiatives essential for industry leaders.